Clinical Trial Update: A Study of Risdiplam (RO7034067) in Adult and Pediatric Participants With Spinal Muscular Atrophy [Phase 2]

View source ↗

Summary

Phase 2 results from a study of risdiplam in adult and pediatric participants with Spinal Muscular Atrophy have been completed and posted. The document summariz…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Drugs mentioned

• Risdiplam (risdiplam)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Spinal Muscular Atrophy | Phase 2 | Status: COMPLETED | Results posted: 2025-10-01